59. D.E. Lee, J.H. Na, S. Lee, C.M. Kang, H.N. Kim, S.J. Han et al., Facile method to radiolabel
glycol chitosan nanoparticles with
64
Cu via copper-free click chemistry for microPET
imaging. Mol. Pharm. 10(6), 2190–2198 (2013)
60. A. Ruggiero, C.H. Villa, J.P. Holland, S.R. Sprinkle, C. May, J.S. Lewis et al., Imaging and
treating tumor vasculature with targeted radiolabeled carbon nanotubes. Int. J. Nanomed. 5,
783–802 (2010)
61. K.J. Harrington, S. Mohammadtaghi, P.S. Uster, D. Glass, A.M. Peters, R.G. Vile et al.,
Effective targeting of solid tumors in patients with locally advanced cancers by radiolabeled
pegylated liposomes. Clin. Cancer Res. 7(2), 243–254 (2001)
62. Y.J. Chang, C.H. Chang, T.J. Chang, C.Y. Yu, L.C. Chen, M.L. Jan et al., Biodistribution,
pharmacokinetics and microSPECT/CT imaging of
188
Re-bMEDA-liposome in a C26 murine
colon carcinoma solid tumor animal model. Anticancer Res. 27(4b), 2217–2225 (2007)
63. F. Chen, H. Hong, Y. Zhang, H.F. Valdovinos, S. Shi, G.S. Kwon et al., In vivo tumor
targeting and image-guided drug delivery with antibody-conjugated, radiolabeled mesoporous
silica nanoparticles. ACS Nano 7(10), 9027–9039 (2013)
64. R. Zhang, Q. Fan, M. Yang, K. Cheng, X. Lu, L. Zhang et al., Engineering melanin
nanoparticles as an efficient drug-delivery system for imaging-guided chemotherapy. Adv.
Mater. 27(34), 5063–5069 (2015)
65. S.X. Wang, A. Bao, S.J. Herrera, W.T. Phillips, B. Goins, C. Santoyo et al., Intraoperative
186
Re-liposome radionuclide therapy in a head and neck squamous cell carcinoma xenograft
positive surgical margin model. Clin. Cancer Res. 14(12), 3975–3983 (2008)
66. H.-E. Wang, H.-M. Yu, Y.-C. Lu, N.-N. Heish, Y.-L. Tseng, K.-L. Huang et al., Internal
radiotherapy and dosimetric study for
111
In/
177
Lu-pegylated liposomes conjugates in
tumor-bearing mice. Nucl. Instrum. Methods Phys. Res. A. 569(2), 533–537 (2006)
67. L.C. Chen, C.H. Chang, C.Y. Yu, Y.J. Chang, W.C. Hsu, C.L. Ho et al., Biodistribution,
pharmacokinetics and imaging of
188
Re-BMEDA-labeled pegylated liposomes after intraperitoneal injection in a C26 colon carcinoma ascites mouse model. Nucl. Med. Biol. 34(4), 415–
423 (2007)
68. L. Li, C.A. Wartchow, S.N. Danthi, Z. Shen, N. Dechene, J. Pease et al., A novel
antiangiogenesis therapy using an integrin antagonist or anti-Flk-1 antibody coated
90
Y-labeled nanoparticles. Int. J. Radiat. Oncol. Biol. Phys. 58(4), 1215–1227 (2004)
69. S. Yook, Z. Cai, Y. Lu, M.A. Winnik, J.P. Pignol, R.M. Reilly, Intratumorally injected
177
Lu-labeled gold nanoparticles: Gold nanoseed brachytherapy with application for
neoadjuvant treatment of locally advanced breast cancer. J. Nucl. Med. 57(6), 936–942 (2016)
70. L. Apetoh, F. Ghiringhelli, A. Tesniere, M. Obeid, C. Ortiz, A. Criollo et al., Toll-like
receptor 4-dependent contribution of the immune system to anticancer chemotherapy and
radiotherapy. Nat. Med. 13(9), 1050–1059 (2007)
71. M. Obeid, T. Panaretakis, N. Joza, R. Tufi, A. Tesniere, P. van Endert et al., Calreticulin
exposure is required for the immunogenicity of gamma-irradiation and UVC light-induced
apoptosis. Cell Death Differ. 14(10), 1848–1850 (2007)
72. C. Vanpouille-Box, F. Lacoeuille, C. Belloche, N. Lepareur, L. Lemaire, J.-J. LeJeune et al.,
Tumor eradication in rat glioma and bypass of immunosuppressive barriers using internal
radiation with
188
Re-lipid nanocapsules. Biomaterials 32(28), 6781–6790 (2011)
250
Y.-S. Lee et al.
glycol chitosan nanoparticles with
64
Cu via copper-free click chemistry for microPET
imaging. Mol. Pharm. 10(6), 2190–2198 (2013)
60. A. Ruggiero, C.H. Villa, J.P. Holland, S.R. Sprinkle, C. May, J.S. Lewis et al., Imaging and
treating tumor vasculature with targeted radiolabeled carbon nanotubes. Int. J. Nanomed. 5,
783–802 (2010)
61. K.J. Harrington, S. Mohammadtaghi, P.S. Uster, D. Glass, A.M. Peters, R.G. Vile et al.,
Effective targeting of solid tumors in patients with locally advanced cancers by radiolabeled
pegylated liposomes. Clin. Cancer Res. 7(2), 243–254 (2001)
62. Y.J. Chang, C.H. Chang, T.J. Chang, C.Y. Yu, L.C. Chen, M.L. Jan et al., Biodistribution,
pharmacokinetics and microSPECT/CT imaging of
188
Re-bMEDA-liposome in a C26 murine
colon carcinoma solid tumor animal model. Anticancer Res. 27(4b), 2217–2225 (2007)
63. F. Chen, H. Hong, Y. Zhang, H.F. Valdovinos, S. Shi, G.S. Kwon et al., In vivo tumor
targeting and image-guided drug delivery with antibody-conjugated, radiolabeled mesoporous
silica nanoparticles. ACS Nano 7(10), 9027–9039 (2013)
64. R. Zhang, Q. Fan, M. Yang, K. Cheng, X. Lu, L. Zhang et al., Engineering melanin
nanoparticles as an efficient drug-delivery system for imaging-guided chemotherapy. Adv.
Mater. 27(34), 5063–5069 (2015)
65. S.X. Wang, A. Bao, S.J. Herrera, W.T. Phillips, B. Goins, C. Santoyo et al., Intraoperative
186
Re-liposome radionuclide therapy in a head and neck squamous cell carcinoma xenograft
positive surgical margin model. Clin. Cancer Res. 14(12), 3975–3983 (2008)
66. H.-E. Wang, H.-M. Yu, Y.-C. Lu, N.-N. Heish, Y.-L. Tseng, K.-L. Huang et al., Internal
radiotherapy and dosimetric study for
111
In/
177
Lu-pegylated liposomes conjugates in
tumor-bearing mice. Nucl. Instrum. Methods Phys. Res. A. 569(2), 533–537 (2006)
67. L.C. Chen, C.H. Chang, C.Y. Yu, Y.J. Chang, W.C. Hsu, C.L. Ho et al., Biodistribution,
pharmacokinetics and imaging of
188
Re-BMEDA-labeled pegylated liposomes after intraperitoneal injection in a C26 colon carcinoma ascites mouse model. Nucl. Med. Biol. 34(4), 415–
423 (2007)
68. L. Li, C.A. Wartchow, S.N. Danthi, Z. Shen, N. Dechene, J. Pease et al., A novel
antiangiogenesis therapy using an integrin antagonist or anti-Flk-1 antibody coated
90
Y-labeled nanoparticles. Int. J. Radiat. Oncol. Biol. Phys. 58(4), 1215–1227 (2004)
69. S. Yook, Z. Cai, Y. Lu, M.A. Winnik, J.P. Pignol, R.M. Reilly, Intratumorally injected
177
Lu-labeled gold nanoparticles: Gold nanoseed brachytherapy with application for
neoadjuvant treatment of locally advanced breast cancer. J. Nucl. Med. 57(6), 936–942 (2016)
70. L. Apetoh, F. Ghiringhelli, A. Tesniere, M. Obeid, C. Ortiz, A. Criollo et al., Toll-like
receptor 4-dependent contribution of the immune system to anticancer chemotherapy and
radiotherapy. Nat. Med. 13(9), 1050–1059 (2007)
71. M. Obeid, T. Panaretakis, N. Joza, R. Tufi, A. Tesniere, P. van Endert et al., Calreticulin
exposure is required for the immunogenicity of gamma-irradiation and UVC light-induced
apoptosis. Cell Death Differ. 14(10), 1848–1850 (2007)
72. C. Vanpouille-Box, F. Lacoeuille, C. Belloche, N. Lepareur, L. Lemaire, J.-J. LeJeune et al.,
Tumor eradication in rat glioma and bypass of immunosuppressive barriers using internal
radiation with
188
Re-lipid nanocapsules. Biomaterials 32(28), 6781–6790 (2011)
250
Y.-S. Lee et al.